The degree of plasma-protein binding has a significant effect on the pharmacokinetic and pharmacodynamic outcomes in vivo. Many critical pharmacokinetic parameters, such as the hepatic metabolism rate, renal excretion rate, biomembrane partition rate, and steady-state distribution volume are a function of the unbound drug fraction. 1 Therefore, the quantitative determination of drug-protein binding is important in clinical drug development.
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Within plasma proteins, serum albumin is undoubtedly the most important carrier for drugs and other small molecules. Thus, the attention of many scientists has been drawn to the phenomenon of the interactions between drug and serum albumin. Because of the relative ease of the experiments, most standard binding assays use serum albumin. 2 Many methodologies have been used for the quantitative determination of drug-protein binding. Among those, equilibrium dialysis and ultrafiltration, followed by HPLC analysis, have been conventionally and most commonly used. [3] [4] [5] Equilibrium dialysis separates molecules across a semi-permeable membrane according to the molecular size (weight) by utilizing the driving force of the concentration difference between solutions on each side of the membrane. Ultrafiltration is a method that rapidly (usually within 10 min) separates free small molecules from protein-bound ones using a membrane. Such conventional methods suffer from a relatively long analysis time (hours for equilibrium dialysis) and the consumption of large volume samples. 6 Furthermore, for compounds highly binding to proteins, the concentration of the free drug is frequently low and difficult to detect.
Thus, chromatographic [7] [8] [9] and electrophoretic 10 techniques have been developed for this purpose. These methods, which are usually based on soluble or immobilized proteins and drugs, are characterized by intrinsic disadvantages. The use of immobilized ligands in a chromatographic system makes it possible to reuse the same preparation of ligands for multiple experiments; however, the immobilization process can affect the protein activity through denaturation, improper orientation or steric hindrance of the protein at the binding sites. Liquid-liquid extraction (LLE) is the most commonly used technique for sample isolation and enrichment. However, liquid-liquid extraction has many disadvantages as it is tedious, labor-intensive and time-consuming. Liquid-liquid extraction in particular requires the use of large volume of highly purified solvents, which are often hazardous and result in the production of toxic laboratory waste. Prior to a chromatographic analysis, there is a need for solvent evaporation in order to preconcentrate the samples.
In response to the problems associated with the traditional liquid-liquid extraction, efforts have been directed towards miniaturizing the liquid-liquid extraction procedure by greatly reducing the solvent to an aqueous phase volume ratio. Several novel microextraction techniques have been developed. [12] [13] [14] [15] [16] As the analytes move from the bulk sample to the drop, they are effectively preconcentrated. However, the drop is unstable under stirring conditions and in samples with significant particulate matter. To overcome this limitation, a hollow-fiber membrane solvent microextraction (HFMSME) system has been developed that uses a piece of hollow fiber membrane filled with an acceptor solution. [17] [18] [19] [20] In this microextraction system, a piece of polypropylene hollow-fiber membrane is filled from one end with 15 -25 μL of the acceptor solution and placed into the sample. The analytes can partition between the bulk aqueous phase and the organic phase contained in the pores of the membrane. The acceptor solution is then removed from the fiber and introduced into separation instrumentation for analysis. HFMSME allows for the sample to be stirred more vigorously, thus reducing the Nernst diffusion layer and improving the extraction efficiency. This improves the rate and efficiency of analytes transferred across the membrane.
In the present work, we applied this technique to determine protein binding with drugs. Results indicate that this method is fast and simple, and overcomes the drawbacks of the conventional analytical techniques. A new direct method has been developed to determine protein-drug binding based on hollow fiber membrane solvent microextraction. Hollow-fiber membrane solvent microextraction coupled with high-performance chromatography with UV detection was employed to evaluate the binding characteristics of drugs to bovine serum albumin (BSA) and blood serum. It was found that the BSA and matrix in the blood serum did not interfere with the measurement. The method is simple and fast. It lacks the drawbacks of some conventional analytical techniques, such as taking much long time and requiring large volume sample consumption. 
Theory
The binding between a drug and a protein can be described by the following equation:
Here, [D] , [P] and [DP] are the concentrations at equilibrium of the drug, protein, and drug-protein complex, respectively. Kp is the drug-protein binding constant, which is given by
We assume that the initial concentration of drug is [D0], i.e.,
The fraction of the bound drug concentration, fd, at this equilibrium is
Experimental Chemicals Dehydroandrograhohide (AR) was purchased from the Institute of Drug and Biological Product Analysis, Beijing, China. Hydrocortisone was kindly provided by the Institute of Tianjin Drug Analysis, Tianjin, China. Bovine serum albumin (BSA), fraction V, (electrophoresis: 100%, La Jolla, CA) was purchased from Bioscience Inc., USA. n-Octanol (AR) was purchase from Keiwei Com., Tianjin, China. All organic solvents used were of HPLC grade. The HPLC mobile phase was filtered through a 0.45 μm nylon membrane before being used. Water was doubly distilled. Newborn calf serum was purchased from Promega Life Science (Tianjin, China) and stored in the dark at -20˚C.
Working solution preparation
A hydrocortisone methanol stock solution (1 mM) was prepared and stored in the dark at 4˚C. A dehydroandrograhohide methanol stock solution (1 mM) was prepared and stored in the dark at 4˚C. More dilute solutions were prepared in phosphate buffer (0.1 M, pH 7.4, water used in the buffer presaturated by n-octanol) just before being used, and filtered through a 0.45 μm fiber membrane. Bovine serum albumin (BSA, 1 mM) was prepared and stored in the dark at -20˚C.
Chicken blood serum preparation
Chicken blood serum was made according to a reference 21 in our lab. Chicken blood centrifuging was carried out for 20 min at a speed of 2000 rpm. Chicken blood serum was separated and filtered through a 0.45 μm fiber membrane and stored in the dark at -20˚C.
Apparatus
The hollow polypropylene fiber membrane (Institute of Membrane Research, School of Chemical Engineering, Tianjin University, Tianjin, China) used was 1 mm i.d. with a pore size
of 0.08 μm (Fig. 1) . The porous ratio percent was 60%.
Chromatography was performed using a 150 mm × 3.9 mm i.d., Symmetry C18 column (Waters Corporation, USA), a ConstaMetric 4100 solvent deliver system (Thermo Separation Products USA), and a Waters 486 tunable absorbance detector (Waters Corporation). Data were taken by Chrom perfect dataacquisition software (Justice Innovation, USA).
Chromatographic and detection conditions
The mobile phase consisted of acetonitrile/redistilled water (50:50, v/v) for hydrocortisone and methanol/water (60:40, v/v) for dehydroandrograhohide. The flow rate was 0.5 ml/min and the temperature was ambient. The detection wavelengths were 250 nm for hydrocortisone and 252 nm for dehydroandrograhohide.
n-Octanol and hollow fiber membrane pretreatment
After 100 ml of n-octanol and 1000 ml of water were mixed and shaken for 10 min, the mixer was left standing for 24 h. The mixture was then separated by a separatory funnel. Therefore, water in the aqueous phase used in the measurement was presaturated by n-octanol, and n-octanol used in the organic phase was presaturated by water. The hollow-fiber membrane was washed three times by methanol. The fiber was then cut into about 6 cm length.
Drug distribution coefficient, P, between n-octanol and the buffer solution measurement
In the present work, the hollow fiber solvent microextraction method was used to measure the drug distribution coefficient, P, between the n-octanol phase and the buffer solution phase. Hydrocortisone was prepared at a concentration of 1 × 10 -2 M DMSO as stock solutions, then 12.5 μl was added to a vial, diluted by a phosphate buffer solution (0.1 M, pH 7.4) to 2 ml. The concentration was 20 μg/ml. The hollow-fiber membrane was sealed at one end on a flame. Then, 25 μl n-octanol (saturated by water) was injected into the tube, and the other end was sealed. For partitioning, the tube was put in a vial, and shaken for 60 min at room temperature. The n-octanol phase was taken from the tube by a syringe and diluted 100 times by methanol. Then, 10 μl of each phase sample was injected and analyzed by LC, respectively.
Drug-BSA studies
Working solutions were prepared in 15 ml bottles by dissolving proper amounts of detection compounds into 15 ml of phosphate buffer (0.1 M, pH 7.4). Suitable amounts of BSA were added to the working solutions, respectively. The samples 1566 ANALYTICAL SCIENCES DECEMBER 2006, VOL. 22 were equilibrated at 37˚C in a water bath for 2 h. After equilibrium had been reached, a hollow fiber containing noctanol was placed in the bottle. Extraction was carried out at room temperature for 60 min under magnetic stirring. The sample in the n-octanol phase was taken out using a syringe, and a 15 μl sample was injected and the concentration of the free drug in the sample was analyzed by LC. The amount bound to the protein was calculated as the difference between the initial concentration and that of the free analyte.
Drug-protein in the blood serum studies
Working solutions were prepared in a 15 ml bottle by dissolving a proper amount of detection compound into 13.5 ml phosphate buffer (0.1 M, pH 7.4); 1.5 ml a blood serum was then added to the working solutions, respectively. The next procedure was the same as the procedure of drug-BSA studies.
Results and Discussion

Effects of the hollow-fiber membrane
In order to clarify the interferences concerning the membrane and to make sure that the hollow-fiber tube works, the hollow fiber membrane tubes were washed three times with methanol. To be certain of no contaminations on the membrane, a blank test indicated that nothing could be detected when the water phase had no test compound in it; therefore, to exclude the membrane effect, water instead of n-octanol was placed in the tube as the extract solvent. Figure 2 shows that the peak areas of hydrocortisone in the aqueous solutions of two sides were almost equal. All of these results demonstrate that the hollowfiber membrane tubes used in this study worked well, and did not interfere with the determination.
Effects of some parameters on the equilibrium
It is believed that the test compound forms thermodynamics equilibrium between the n-octanol phase and the water phase; therefore, the chemical potentials of the compound in the two phases are equal. For this reason, the concentration ratio of a compound between two phases at equilibrium is a constant. This is the basic assumption of all measurements. It was expected that some parameters, such as the temperature and pH, would influence the equilibrium and solvent microextraction efficiency. In our experiment, we controlled the experiment at room temperature and the buffer pH at 7.4, which is close to the biological pH.
We added n-octanol to a hollow fiber tube, which remained in the tube for hydrophobicity. The current method allows the sample to be stirred more vigorously, which reduces the Nernst diffusion layer. Therefore, it improves extraction efficiency and reduces extraction time; thus, extraction is finished in a shorter time. Further, there is no emulsion at the interface between noctanol and the water phases. Thus, the n-octanol phase and the water phase can be completely separated. Extraction in this experiment was carried out under magnetic stirring at a speed of 600 rpm. The time for the test compound to reach equilibrium was examined under this condition. It was found that the hydrocortisone concentration in n-octanol phase continued to increase with the extraction time up to 40 min and the hydrocortisone concentration in n-octanol phase reached the maximum and level off when the time exceeded 40 min. This demonstrated that the equilibrium was reached when the time exceeded 40 min. The extraction time was also affected by the initial concentration of the test compounds. At higher concentrations, it took longer time to reach the equilibrium. All of the compounds used in this study reached equilibrium between the two phases in less than 60 min.
Effect of hollow fiber solvent microextraction on the interactions between a drug and a protein
Hollow-fiber solvent microextraction is known to be a partition extraction technique. Thus, if the volumes of two phases are significantly different, the absolute amount in the smaller phase is neglected compared to the other phase. Therefore, the amount of drug extracted from a much larger volume of aqueous drug solution to the microtube is so small that it should not disturb the reversible equilibrium between the drug and the protein. For example, we determined the log P values of hydrocortisone to be 2.19 (Table 1 ). In our experiment, the aqueous solution volume, Va, was 15 ml and the volume of n-octanol in the the microtube, Vo, was only 25 μl. Assuming the initial drug concentration in the aqueous phase ca,i = 100 ng/ml and ca,e for the initial and at the equilibrium, respectively. The drug concentrations in the n-octanol phase were co,i = 0 and co,e for the initial stage and at equilibrium, respectively. At equilibrium, the following relationship existed:
ca,iVa = co,eVo + ca,eVa, i.e., 100 ng/ml × 15 ml = ca,e × 15 ml + co,e × 0.0025 ml.
(
Since the partition coefficient, P, was co/cw = 10 2 , 19 (2) it is easy to obtain ca,e = 97.48 ng/ml. From this calculation, it is clear to see that the amount of drug to be extracted out of the aqueous solution is related to both volume ratio and the log P of the compound, i.e.,
The % impact is (4) In this case, the concentration change in the aqueous was only 2.52%. This small amount of variation did not change the characteristics of the protein binding. At the same time, BSA or the protein in the blood do not enter the n-octanol phase due to hydrophobicity. Therefore, the extraction amount of the free drug in the aqueous solution using hollow fiber solvent microextraction method had negligible interference on the equilibrium between the drug and the protein.
Measurement of drug-protein binding
The above discussion has laid the basis for determining the concentration of free drug in the presence of BSA at pH 7.4. The extracted compound can be determined by LCUV. Figure  4 shows a chromatogram of a standard solution of hydrocortisone at a concentration of 100 ng/ml and the same concentration of solution in the presencece of BSA. As expected, a significant difference was observed with and without the presence of BSA. This clearly indicates the occurrence of BSA-hydrocortisone binding. A similar peak difference was observed when BSA was replaced with blood serum.
Calibration curve A series of standard drug solutions were prepared in the concentration range from 10 to 200 ng/ml for hydrocortisone and from 20 to 800 ng/ml for dehydroandrograhohide. Hollow fiber tubes containing 25 μl octanol were placed in these standard solutions, respectively. When equilibrium was reached, the drug in n-octanol was analyzed by the HPLC method. Calibration curves were obtained by plotting the peak area of the drug in n-octanol against the drug concentration in the aqueous standard solutions. The calibration curves were y = 4035x + 9080 (R 2 = 0.9969, n = 5) for hydrocortisone and y = 9817x -107635 (R 2 = 0.9981, n = 5) for dehydroandrograhohide.
Sample analysis and protein-drug binding determination
According to the calibration curves, the free drug concentrations in buffer solution in the presence of BSA or blood serum were determined ( Table 2 ). The bound drug concentrations [DP] were calculated by subtracting the total drug concentration [D0] from the free drug concentration [D] . The fraction of bound drug concentration, fd, at this equilibrium was calculated by Eq. (4) given in the Theory section (Table 3) . The determined fraction of the bound drug concentration, fd, was similar to that reported in literature. 22 Water phase/ µg ml 
